European Journal of Epidemiology

, Volume 23, Issue 1, pp 67–74

Universal risk factors for multifactorial diseases

LifeLines: a three-generation population-based study
  • Ronald P. Stolk
  • Judith G. M. Rosmalen
  • Dirkje S. Postma
  • Rudolf A. de Boer
  • Gerjan Navis
  • Joris P. J. Slaets
  • Johan Ormel
  • Bruce H. R. Wolffenbuttel
NEW STUDY

Abstract

The risk for multifactorial diseases is determined by risk factors that frequently apply across disorders (universal risk factors). To investigate unresolved issues on etiology of and individual’s susceptibility to multifactorial diseases, research focus should shift from single determinant-outcome relations to effect modification of universal risk factors. We present a model to investigate universal risk factors of multifactorial diseases, based on a single risk factor, a single outcome measure, and several effect modifiers. Outcome measures can be disease overriding, such as clustering of disease, frailty and quality of life. “Life course epidemiology” can be considered as a specific application of the proposed model, since risk factors and effect modifiers of multifactorial diseases typically have a chronic aspect. Risk factors are categorized into genetic, environmental, or complex factors, the latter resulting from interactions between (multiple) genetic and environmental factors (an example of a complex factor is overweight). The proposed research model of multifactorial diseases assumes that determinant-outcome relations differ between individuals because of modifiers, which can be divided into three categories. First, risk-factor modifiers that determine the effect of the determinant (such as factors that modify gene-expression in case of a genetic determinant). Second, outcome modifiers that determine the expression of the studied outcome (such as medication use). Third, generic modifiers that determine the susceptibility for multifactorial diseases (such as age). A study to assess disease risk during life requires phenotype and outcome measurements in multiple generations with a long-term follow up. Multiple generations will also enable to separate genetic and environmental factors. Traditionally, representative individuals (probands) and their first-degree relatives have been included in this type of research. We put forward that a three-generation design is the optimal approach to investigate multifactorial diseases. This design has statistical advantages (precision, multiple-informants, separation of non-genetic and genetic familial transmission, direct haplotype assessment, quantify genetic effects), enables unique possibilities to study social characteristics (socioeconomic mobility, partner preferences, between-generation similarities), and offers practical benefits (efficiency, lower non-response). LifeLines is a study based on these concepts. It will be carried out in a representative sample of 165,000 participants from the northern provinces of the Netherlands. LifeLines will contribute to the understanding of how universal risk factors are modified to influence the individual susceptibility to multifactorial diseases, not only at one stage of life but cumulatively over time: the lifeline.

Keywords

Multifactorial disease Effect modification Gene–environment Biobank 

References

  1. 1.
    World Health Organisation. World Health Report 2002; Reducing risk, promoting healthy life. Geneva: World Health Organisation; 2002.Google Scholar
  2. 2.
    De Stavola BL, Nitsch D, dos Santos Silva I, et al. Statistical issues in life course epidemiology. Am J Epidemiol. 2006;163:84–96.PubMedCrossRefGoogle Scholar
  3. 3.
    Barker DJ, Eriksson JG, Forsen T, et al. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31:1235–39.PubMedCrossRefGoogle Scholar
  4. 4.
    Zaher C, Halbert R, Dubois R, et al. Smoking-related diseases: the importance of COPD. Int J Tuberc Lung Dis. 2004;8:1423–8.PubMedGoogle Scholar
  5. 5.
    Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull. 1996;52:58–73.PubMedGoogle Scholar
  6. 6.
    Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005;95 Suppl 1:S144–50.PubMedCrossRefGoogle Scholar
  7. 7.
    Kelada SN, Eaton DL, Wang SS, et al. The role of genetic polymorphisms in environmental health. Environ Health Perspect. 2003;111:1055–64.PubMedGoogle Scholar
  8. 8.
    Aneshensel CS, Frerichs RR, Huba GJ. Depression and physical illness: a multiwave, nonrecursive causal model. J Health Soc Behav. 1984;25:350–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Hotopf M, Mayou R, Wadsworth M, et al. Temporal relationships between physical symptoms and psychiatric disorder - Results from a national birth cohort. Br J Psychiatry 1998;173:255–61.PubMedGoogle Scholar
  10. 10.
    Stansfeld SA, Smith GD, Marmot M. Association between physical and psychological morbidity in the Whitehall II Study. J Psychosom Res. 1993;37:227–38.PubMedCrossRefGoogle Scholar
  11. 11.
    Cynader MS. Mechanisms of brain-development and their role in health and well-being. Daedalus 1994;123:155–65.Google Scholar
  12. 12.
    Plagemann A. Fetal programming and functional teratogenesis: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks. J Perinat Med. 2004;32:297–305.PubMedCrossRefGoogle Scholar
  13. 13.
    Power C, Hertzman C. Social and biological pathways linking early life and adult disease. Br Med Bull. 1997;53:210–21.PubMedGoogle Scholar
  14. 14.
    Sayed-Tabatabaei FA, Oostra BA, Isaacs A, et al. ACE polymorphisms. Circ Res. 2006;98:1123–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Neil JR, Galliher AJ, Schiemann WP. TGF-beta in cancer and other diseases. Future Oncol. 2006;2:185–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Russo C, Polosa R. TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin Sci (Lond). 2005;109:135–42.CrossRefGoogle Scholar
  17. 17.
    Pereira MA, Kartashov AI, Ebbeling CB, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 2005;365:36–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Tennant C. Life events, stress and depression: a review of recent findings. Aust N Z J Psychiatry 2002;36:173–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Ormel J, Oldehinkel AJ, Brilman EI. The interplay and etiological continuity of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life. Am J Psychiatry 2001;158:885–91.PubMedGoogle Scholar
  21. 21.
    Lichtenstein P, Pedersen NL. Does genetic variance for cognitive abilities account for genetic variance in educational achievement and occupational status? A study of twins reared apart and twins reared together. Soc Biol. 1997;44:77–90.PubMedGoogle Scholar
  22. 22.
    Kessler RC, Foster CL, Saunders WB, et al. Social consequences of psychiatric disorders, I: educational attainment. Am J Psychiatry 1995;152:1026–32.PubMedGoogle Scholar
  23. 23.
    Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102:10604–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23:455–68.CrossRefGoogle Scholar
  26. 26.
    van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity; what’s in a name? A review of the literature. Eur J Gen Pract. 1996;2:65–70.CrossRefGoogle Scholar
  27. 27.
    van den Akker M, Buntinx F, Metsemakers JFM, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367–75.PubMedCrossRefGoogle Scholar
  28. 28.
    Guralnik JM, Kaplan GA. Predictors of healthy aging: prospective evidence from the Alameda County study. Am J Public Health 1989;79:703–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Von KM, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.CrossRefGoogle Scholar
  30. 30.
    Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255–63.PubMedGoogle Scholar
  31. 31.
    Ormel J, Vonkorff M, Ustun TB, et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994;272:1741–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf) 2005;27:281–91.CrossRefGoogle Scholar
  33. 33.
    Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625–34.PubMedCrossRefGoogle Scholar
  34. 34.
    Rockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2004;59:1310–7.PubMedGoogle Scholar
  35. 35.
    Boxenbaum H. Gompertz mortality analysis: aging, longevity hormesis and toxicity. Arch Gerontol Geriatr. 1991;13:125–37.PubMedCrossRefGoogle Scholar
  36. 36.
    Quantitative Genetic Theory. In: Plomin R, De Fries JC, McClearn GE, et al., editors. Behavioral genetics. A primer.4th ed. New York: Freeman & co; 2000. p. 207–254.Google Scholar
  37. 37.
    Luo S, Klohnen EC. Assortative mating and marital quality in newlyweds: a couple-centered approach. J Pers Soc Psychol. 2005;88:304–26.PubMedCrossRefGoogle Scholar
  38. 38.
    Collins FS. The case for a US prospective cohort study of genes and environment. Nature 2004;429:475–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Barbour V. UK Biobank: a project in search of a protocol? Lancet 2003;361:1734–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138–47.PubMedCrossRefGoogle Scholar
  41. 41.
    http://www.p3gconsortium.org. 2006. Accessed Dec 2007.
  42. 42.
    http://www.genome.gov/13014436. 2006. Accessed Dec 2007.

Copyright information

© The Author(s) 2007

Authors and Affiliations

  • Ronald P. Stolk
    • 1
  • Judith G. M. Rosmalen
    • 2
  • Dirkje S. Postma
    • 3
  • Rudolf A. de Boer
    • 4
  • Gerjan Navis
    • 5
  • Joris P. J. Slaets
    • 6
  • Johan Ormel
    • 2
  • Bruce H. R. Wolffenbuttel
    • 7
  1. 1.Department of Epidemiology, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  2. 2.Department of Psychiatry, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  3. 3.Department of Pulmonology, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  4. 4.Department of Cardiology, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  5. 5.Department of Nephrology, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  6. 6.Department of Geriatrics, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  7. 7.Department of Endocrinology, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands

Personalised recommendations